Vincerx Pharma (VINC) Revenue & Revenue Breakdown
Vincerx Pharma Revenue Highlights
00
Vincerx Pharma Revenue by Period
Vincerx Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Vincerx Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.31M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | -100.00% |
2021-03-31 | $127.00K | -109.07% |
2020-12-31 | $-1.40M | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | - |
Vincerx Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CHRS | Coherus BioSciences | $257.24M | $70.77M |
SPRO | Spero Therapeutics | $96.73M | $13.47M |
APLT | Applied Therapeutics | $9.99M | $144.00K |
BOLT | Bolt Biotherapeutics | $7.88M | $1.14M |
LVTX | LAVA Therapeutics | $6.77M | $6.99M |
XOMA | XOMA | $4.76M | $7.20M |
SNTI | Senti Biosciences | $2.56M | - |
STTK | Shattuck Labs | $1.66M | $1.61M |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
VCNX | Vaccinex | $570.00K | $52.00K |
RZLT | Rezolute | - | - |
BCAB | BioAtla | - | $11.00M |
TARA | Protara Therapeutics | - | - |
PCSA | Processa Pharmaceuticals | - | - |
MNPR | Monopar Therapeutics | - | - |
VINC | Vincerx Pharma | - | - |
SRZN | Surrozen | - | - |